Atlas Trials

A Study of JNJ-53718678 in Participants With Hepatic Impairment

Clinical trial NCT04332523 · TERMINATED

Trial details

NCT number
NCT04332523
Sponsor
Janssen Research & Development, LLC
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2020-08-17
Primary completion
2022-03-16
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.